MedTrace Logo

Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis Patients

NCT03796715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-01-08

No results posted yet for this study

Summary

Presepsin (soluble CD14 subtype) is a novel marker with growing body of evidence supporting its accuracy and value for the diagnosis of sepsis. Patients with sepsis showed higher Prsepsin levels compared to those with SIRS. In addition the increase in Prsepsin levels correlates well with sepsis severity. Red cell distribution width variations are increased in a variety of medical conditions such as congestive heart failure, acute myocardial infarction, pulmonary embolism, pneumonia, critical illness, and cardiac arrest , and is a predictor of mortality in the general population. we aim to compare between Presepsin (soluble CD14) and RDW as prognostic markers in critically-ill patients with sepsis.

Conditions

Interventions

DIAGNOSTIC_TEST

Red Cell Distribution Width (RDW)

A total of 100 sepsis patients, Red Cell Distribution Width (RDW) was used as prognostic marker.

DIAGNOSTIC_TEST

Presepsin (sCD14-ST)

: A total of 100 sepsis patients, Presepsin (sCD14-ST) was used as prognostic marker.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Ahmed Elsayed · Ain Shams University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2018-11-20
Completion
2018-12-24

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796715 on ClinicalTrials.gov